A deadline looms to sign drug-price negotiation agreements as industry watches for legal reprieve.
Several major drugmakers, including Merck & Co. Inc. MRK, -0.51% and AstraZeneca PLC AZN, +1.36%, say they’re moving forward with the Medicare drug-price negotiation process ahead of this Sunday’s deadline to sign agreements to participate–but industry players are also waiting for a key legal ruling that could put the program on pause ahead of that date.
Merck, which was the first drugmaker to allege in court that the negotiation program is unconstitutional, said in a statement to MarketWatch that it will sign the initial agreement “under protest” as it remains focused on challenging the program in court. The company’s blockbuster diabetes drug Januvia was among the drugs selected in late August for the first Medicare negotiations.
Other major drugmakers affected by the negotiation process are likely to participate, analysts say, but may be holding out for a potentially favorable ruling on the Chamber of Commerce request for a preliminary injunction. Judge Michael Newman of U.S. District Court for the Southern District of Ohio, an appointee of former President Donald Trump, heard oral arguments on the issue on Sept. 15 but has not yet ruled on the request.
Drugmakers have until Monday to submit data for Medicare to consider in negotiating a maximum fair price for the selected drugs.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
AstraZeneca, Boehringer Ingelheim to participate in Medicare drug price negotiationsAstraZeneca, Boehringer Ingelheim and other drugmakers have filed at least eight lawsuits seeking to declare the Medicare price talks unconstitutional.
Read more »
AstraZeneca, Bristol Myers Squibb to participate in Medicare drug price negotiationsAstraZeneca, Bristol Myers Squibb and other drugmakers have filed at least eight lawsuits seeking to declare the Medicare price talks unconstitutional.
Read more »
What is Medicare supplemental insurance?Medicare supplemental insurance can provide valuable financial protection for millions of seniors. Here's what to know.
Read more »
A mistake may have cost seniors thousands in healthcare costs. N.J. is fixing it.People over 65 who don't qualify for Medicare are affected by the change.
Read more »
What would a government shutdown mean for Social Security, SNAP, student loans, Medicare?A handful of federal programs that people nationwide rely on everyday could be disrupted.
Read more »
Long-time patient voices concerns as Scripps Health to exit Medicare AdvantageThat is her message to Scripps. She received an email from Scripps Health that her Medicare Advantage plan will not be in-network for Scripps Clinic and Scripps Coastal doctors, starting next year.
Read more »